Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Exendin-4 for Sale > 99% purity peptide in vials, white lyophilized powder, pre-order available
99% purity peptide in vials, white lyophilized powder, pre-order available buy - large image1
99% purity peptide in vials, white lyophilized powder, pre-order available buy - image1
99% purity peptide in vials, white lyophilized powder, pre-order available buy - image2
99% purity peptide in vials, white lyophilized powder, pre-order available buy - image3
99% purity peptide in vials, white lyophilized powder, pre-order available buy - image4
99% purity peptide in vials, white lyophilized powder, pre-order available buy - image5
99% purity peptide in vials, white lyophilized powder, pre-order available buy - image6

99% purity peptide in vials, white lyophilized powder, pre-order available

4 Inquiries

Unit Price:

$58/UNIT EXW

Get Latest Price
CAS No.:

141758-74-9

Grade:

Research Grade

Content:

99%

Port:

qingdao

Packaging:

5mg;10mg;15mg;20mg;30mg;40mg;50mg;100mg;500mg

Price valid (until):

2026-12-04

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Cosmetics

  • Product Details

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Company Profile

    Our enterprise is dedicated to the development, production and global supply of synthetic peptide raw materials for life science laboratory research. We implement standardized production protocols and a comprehensive quality management system, supported by a professional sales and after-sales team. We can develop tailored material solutions matching customers’ experimental plans, with our business reaching many countries and regions around the world. Upholding good faith and quality-first principles, we stay updated on the latest trends of research raw materials and adjust our supply schedule flexibly. We streamline the whole order process from initial enquiry, order confirmation and production scheduling to final delivery for efficient order handling.

    Product Details

    This offering is research-grade synthetic peptide lyophilized powder. It is produced through chemical synthesis and freeze-drying treatment to secure stable properties. Each batch will be sampled and examined prior to shipment. The lyophilized powder is fine and homogeneous, dissolves readily in suitable solvents and maintains consistent batch performance, well suited for laboratory research work. We support both large bulk purchases; higher purchase volumes come with more competitive unit rates. Custom packaging specifications can be negotiated to accommodate varied laboratory operating habits.

    Quality Assurance

    We maintain strict quality management covering the full workflow from raw material procurement to finished product dispatch. All source materials are purchased from compliant suppliers and undergo inspection before being put into warehouse. Production is carried out in strict accordance with standard operating procedures. After synthesis and purification, finished products go through multiple rounds of testing. Goods can only be warehoused and shipped once they pass all inspection items.

    Packaging and Logistics

    The inner packing adopts light-proof sealed vials. Shock buffering materials are used on the outer package to lower adverse impacts from bumps and temperature changes during transportation. We work with reliable international logistics partners. Goods will be arranged for dispatch within 1–2 business days after payment confirmation, and a tracking number will be provided for you to check delivery status in real time.

    Support Services

    Our sales and technical team serves laboratory procurement clients and responds to your messages within 24 hours. You may contact us for consultation on specification selection, storage methods, order updates or packaging requirements. Custom labelling and repackaging services can be arranged where conditions allow. We keep tracking shipments after departure. If any issues arise upon receipt of goods, please contact us right away and we will arrange timely handling.

    Storage Conditions

    Store the product in a cool, dry, dark and low-temperature environment. Do not allow repeated freezing and thawing. We recommend dividing the product into separate portions for experimental use to reduce the risk of activity loss.

    Important Disclaimer

    This product is for laboratory research use only. The buyer shall ensure that the product is used strictly within the permitted scope of laboratory research.


    Items Specifications
    Product Type Peptide
    Grade Research Grade
    Appearance White/off-white lyophilized powder
    Packaging Sealed vials
    Available Sizes 5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60mg, 100 mg
    MOQ 1 kit (10 vials)



    Shop 99% purity peptide in vials, white lyophilized powder, pre-order available-Detailed Image 1 Shop 99% purity peptide in vials, white lyophilized powder, pre-order available-Detailed Image 2 Shop 99% purity peptide in vials, white lyophilized powder, pre-order available-Detailed Image 3 Shop 99% purity peptide in vials, white lyophilized powder, pre-order available-Detailed Image 4

    ECHEMI Editorial Reference
    Exendin-4 is a 39 amino acid polypeptide and incretin mimetic involved in the glucose-dependent enhancement of insulin secretion. It was first isolated from Gila monster saliva. It also promotes the reduction of hyperglycemia, glucose-dependent suppression of inappropriately high glucagon secretion, slowing of gastric emptying, and reduction of food intake, often with body weight reduction or blunting of weight gain. The synthetic form, Exenatide, is a glucagon-like peptide-1 (GLP-1) agonist approved for the treatment of diabetes mellitus type II, has a long half-life.

    Exenatide is the first drug in a new class of anti-diabetics known as the incretin mimetics, and it is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes who are taking metformin, a sulfonylurea, or both, but have not achieved adequate glycemic control. Exenatide is a functional analog of the human incretin Glucagon-Like Peptide-1 (GLP-1). GLP-1 is naturally released from cells in the GI tract in response to food intake and acts on its receptor on b-cells to potentiate glucose-stimulated insulin secretion. Exenatide is a long-acting agonist at the GLP-1 receptor. It is a synthetic version of a 39-amino acid peptide found in the salivary secretions of the Gila monster lizard.also moderates peak serum glucagon levels during hyperglycemic periods following meals, but does not interfere with glucagon release in response to hypoglycemia. 


    ChEBI: A bioactive polypeptide of 39 amino acid residues isolated from the saliva of the Gila monster (Heloderma suspectum). High-affinity glucagon-like peptide 1 (GLP-1) receptor agonist (Kd = 136 pM); potently indu es cAMP formation without stimulating amylase release in pancreatic acini; potentiates glucose-induced insulin secretion in isolated rat islets; protects against glutamate-induced neurotoxicity. A synthetic version is called exenatide.
    Exendin-4 is an incretin mimetic peptide, which is composed of 39 amino acids. It is an analog of glucagon-like peptide 1 (GLP-1), and an insulinotropic agent, with a long half-life. Exendin-4 was historically isolated from the venom of Gila monster lizard calledHeloderma suspectum.
    Exendin-4 Recombinant produced in E.Coli is a non-glycosylated polypeptide chain containing 39 amino acids and having a molecular mass of approximately 4.2kDa. Exendin-4 is purified by proprietary chromatographic techniques.

    Basic Info
    Product Name:

    Exendin-4

    Other Name:

    HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2;Exenatide (Exendin-4);Exenatide free base;XENDIN-4;EXENDIN-4;M.W. 4186.61 C184H282N50O60S;HIS-GLY-GLU-GLY-THR-PHE-THR-SER-ASP-LEU-SER-LYS-GLN-MET-GLU-GLU-GLU-ALA-VAL-ARG-LEU-PHE-ILE-GLU-TRP-LEU-LYS-ASN-GLY-GLY-PRO-SER-SER-GLY-ALA-PRO-PRO-PRO-SER-NH2;HIS-GLY-GLU-GLY-THR-PHE-THR-SER-ASP-LEU-SER-LYS-GLN-MET-GLU-GLU-GLU-ALA-VAL-ARG-LEU-PHE-ILE-GLU-TRP-LEU-LYS-ASN-GLY-GLY-PRO-SER-SER-GLY-ALA-PRO-PRO-PRO-SER-NH2: HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2

    CAS No.:

    141758-74-9

    Molecular Formula:

    C184H282N50O60S

    InChIKeys:

    HTQBXNHDCUEHJF-XWLPCZSASA-N

    Molecular Weight:

    4187

    EC Number:

    686-356-3

    Color/Form:

    White to off-white powder

    HScode:

    2933290000

    Categories:

    Polypeptide

    Characteristics
    XLogP3:

    -21

    Water Solubility:

    Soluble in water (1 mg/ml)

    Storage Conditions:

    Bydureon should be stored in the refrigerator at 36 °F to 46 °F (2 °C to 8 °C), up to the expiration date or until preparing for use. Bydureon should not be used past the expiration date. The expiration date can be found on the carton, on the cover of the single-dose tray, or on the pen label. Do not freeze Bydureon. Do not use Bydureon if it has been frozen. Protect from light. Bydureon single-dose tray can be kept at room temperature not to exceed 77 °F (25 °C).; Prior to first use, Byetta must be stored refrigerated at 36 °F to 46 °F (2 °C to 8 °C). After first use, Byetta can be kept at a temperature not to exceed 77 °F (25 °C). Do not freeze. Do not use Byetta if it has been frozen. Byetta should be protected from light.

    Toxicity:

    IDENTIFICATION AND USE: Exenatide is a white to off-white powder formulated into solution for subcutaneous use. Exenatide is available in both a twice daily formulation and an extended-release formulation that is administered weekly. Exenatide is a synthetic, long-acting human glucagon-like peptide-1 (GLP-1) receptor agonist (incretin mimetic). It is used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. HUMAN EXPOSURE AND TOXICITY: Overdose of exenatide has been reported in a clinical study. Effects have included severe nausea, severe vomiting, and rapidly declining blood glucose concentrations. Post marketing reports also include acute pancreatitis, including fatal and nonfatal hemorrhagic or necrotizing pancreatitis requiring hospitalization and serious hypersensitivity reactions (e.g. anaphylaxis and angioedema). Deterioration of renal function (e.g., increased serum creatinine concentrations, renal impairment/insufficiency, and chronic renal failure, acute renal failure sometimes requiring hemodialysis or kidney transplantation) has also been reported with the use of exenatide. Exenatide extended-release also caused thyroid C-cell tumors at clinically relevant exposures in rats. It is unknown whether the drug causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans, as human relevance could not be determined by clinical or nonclinical studies. Therefore, exenatide extended release is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2. ANIMAL STUDIES: Exenatide had no adverse effects on fertility when given to male mice at doses up to 760 ug/kg/day. However, exenatide did cause developmental toxicity in rats, mice and rabbits. Fetuses from pregnant rats given subcutaneous doses of exenatide extended-release at 0.3, 1, or 3 mg/kg on gestation days 6, 9, 12, and 15 demonstrated reduced fetal growth at all doses and produced skeletal ossification deficits at 1 and 3 mg/kg in association with maternal effects (decreased food intake and decreased body weight gain). In pregnant mice given sc doses of 6, 68, 460, or 760 ug/kg/day from gestation day 6 through 15 (organogenesis), cleft palate (some with holes) and irregular fetal skeletal ossification of rib and skull bones were observed at 6 ug/kg/day. In pregnant rabbits given sc doses of 0.2, 2, 22, 156, or 260 ug/kg/day from gestation day 6 through 18 (organogenesis), irregular fetal skeletal ossifications were observed at 2 ug/kg/day. Studies for the carcinogenicity potential of exenatide were also conducted in rats. Benign thyroid C-adenomas were observed in female rats given extenatide by sc injection at doses of 18, 70, or 250 ug/kg/day. In another carcinogenicity study with exenatide extended-release male and female rats were administrated doses of 0.3, 1.0, and 3.0 mg/kg by subcutaneous injection every other week.

    Critical Temperature & Pressure:

    −20°C

    Research
    Class:

    GLP-1 receptor agonist (exendin-based, 39-amino-acid peptide)

    Status:

    FDA-approved (Byetta 2005, Bydureon 2012)

    Mechanism:

    A synthetic 39-amino-acid peptide (exendin-4) that acts as a GLP-1 receptor agonist. It is not a GLP-1 analog but shares 53% sequence homology with human GLP-1. Exenatide enhances glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying, and reduces food intake. Bydureon is the extended-release formulation.

    EC50 (GLP1R Ic50):

    3.22 nM

    Source:

    Exendin-4 binding data: Eng J, et al. J Biol Chem. 1992;267(11):7402-7405. DrugBank: DB01276.DOI

    Clinical Development:

    NCT00053397

    FDA:

    Byetta, Bydureon BCise (approved 2005-04-28)

    References
    ChEMBL:

    CHEMBL486

    DrugBank:

    DB01276

    KEGG DRUG:

    D04104

    PubChem:

    PubChem

    Disclaimer:

    Exenatide is FDA-approved as a prescription medicine (Byetta, Bydureon) for type 2 diabetes. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

    Hazard Identification

    Classification of the substance or mixture

    Carcinogenicity, Category 2

    Reproductive toxicity, Category 2

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H351 Suspected of causing cancer

    H361 Suspected of damaging fertility or the unborn child

    Precautionary statement(s)
    Prevention

    P203 Obtain, read and follow all safety instructions before use.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    Response

    P318 IF exposed or concerned, get medical advice.

    Storage

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Cosmetics

    Location:

    Room 204, Unit 1, Building 3, Liming 1st District, Choujiang Subdistrict, Wenwu City, Jinhua City, China (Zhejiang) Pilot Free Trade Zone

    Year of Establishment:

    2026

  • Inquiry History
    4 Inquiries
    Country Product Purchase Quantity Date Posted
    Philippines

    Exenatide (CAS: 141758-74-9)

    10 G Sep 19, 2026
    Philippines

    Exenatide

    10 G Sep 16, 2026
    Philippines

    Exenatide

    10 G Aug 13, 2026
    United States

    Exenatide

    5  Mar 11, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.